Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
2.
Sci Rep ; 11(1): 22764, 2021 11 23.
Article in English | MEDLINE | ID: mdl-34815513

ABSTRACT

The neural circuits of the infant brain are rapidly established near 6 months of age, but neurodevelopmental disorders can be diagnosed only at the age of 2-3 years using existing diagnostic methods. Early diagnosis is very important to alleviate life-long disability in patients through appropriate early intervention, and it is imperative to develop new diagnostic methods for early detection of neurodevelopmental disorders. We examined the serum level of secretogranin II (SCG2) in pediatric patients to evaluate its potential role as a biomarker for neurodevelopmental disorders. A plasmonic immunosensor performing an enzyme-linked immunosorbent assay (ELISA) on a gold nanodot array was developed to detect SCG2 in small volumes of serum. This nanoplasmonic immunosensor combined with tyramide signal amplification was highly sensitive to detect SCG2 in only 5 µL serum samples. The analysis using the nanoplasmonic immunosensor revealed higher serum SCG2 levels in pediatric patients with developmental delay than in the control group. Overexpression or knockdown of SCG2 in hippocampal neurons significantly attenuated dendritic arborization and synaptic formation. These results suggest that dysregulated SCG2 expression impairs neural development. In conclusion, we developed a highly sensitive nanoplasmonic immunosensor to detect serum SCG2, a candidate biomarker for the early diagnosis of neurodevelopmental disorders.


Subject(s)
Biomarkers/blood , Biosensing Techniques/methods , Immunoassay/methods , Nanoparticles/chemistry , Neurodevelopmental Disorders/diagnosis , Neurons/pathology , Secretogranin II/blood , Animals , Case-Control Studies , Child , Early Diagnosis , Hippocampus/metabolism , Hippocampus/pathology , Humans , Neurodevelopmental Disorders/blood , Neurons/metabolism , Rats
3.
Rev Sci Instrum ; 89(11): 113107, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30501298

ABSTRACT

A spectrophotometer that uses a localized surface plasmon resonance phenomenon is a powerful measurement tool in the biotechnology and bioanalysis fields. We propose a novel cuvette design type that can be used for universal spectrophotometers. The novel cuvette design needs a few µl reagent for measuring, and also two chips for measurement can be loaded and measured at the same time. A new cuvette can easily be used several times because of sample chips to be loaded and unloaded since they are mechanically mounted by screws. Therefore, it can offer advantages to users in terms of cost and time. We verify its possibility for use in the biotechnology and bioanalysis fields by a signal enhancement and dual signal detection.


Subject(s)
Lab-On-A-Chip Devices , Nanostructures , Surface Plasmon Resonance/instrumentation , Equipment Design
SELECTION OF CITATIONS
SEARCH DETAIL